We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The next round of key opinion leader (KOL) research into the future of prostate cancer treatment has begun. Through discussions with 12 of the world’s leading oncologists on the unmet needs in existing treatments and the impact pipeline programmes can bri